Pfizer Japan’s Ethical Drug Sales Dip 4.2% on Lipitor Patent Expiry: FY2012 Earnings

Pfizer Japan Pres. Umeda Gives Briefing on FY2012 Earnings Pfizer Japan said on March 1 its ethical drug sales in FY2012 (December 2011-November 2012) fell 4.2% from the previous year to 524.2 billion yen, weighed down by the generic debut...read more